Clinical Trial Update: The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing The Titan intracoronary stent with an Everolimus-eluting Xience V stent in diabetic patients undergoing percutaneous cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Hospital Universitario Infanta Cristina | Conditions: Diabetes Mellitus, Percutaneous Coronary Intervention | Phase 4 | Status: UNKNOWN